Identifying critical pathways regulating autoimmunity in immuno-oncology and arthritis patients
The University of Manchester
Division of Musculoskeletal and Dermatological Sciences
Research Group:
Division of Musculoskeletal and Dermatological Sciences
Background. Immune checkpoint inhibitors (CPIs) such as BLOCKING antibodies targeting CTLA4 (e.g. ipilimumab) have revolutionised the treatment of metastatic cancers by offering long-term remission, by boosting the immune response. Read more
Supervisors: Dr S Viatte, Dr P Martin, Dr MC Christofi
Year round applications
PhD Research Project
Self-Funded PhD Students Only